CVS Health Corporation (NYSE:CVS) saw a downside of -0.58% to close Tuesday at $83.79 after subtracting -$0.49 on the day. The 5-day average trading volume is 3,731,420 shares of the company’s common stock. It has gained $85.32 in the past week. An average of 4,892,850 shares of the company has been traded in the last 20 days, and the 50-day average volume stands at 5,331,376.
The company’s shares have touched a 52-week low of $55.36 and high of $90.61, with the stock’s rally to the 52-week high happening on 05/24/21. YTD, CVS has achieved 22.68% or $15.49. However, the current price is down -7.53%% from the 52-week high price.
3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
On Sep 02, 41 days have gone by since the last insider trading activity for CVS Health Corporation (CVS). Brennan Troyen A (EVP and Chief Medical Officer) most recently sold 2,625 shares at $87.00 per share on Sep 02. This transaction cost the insider $228,375. EVP&President-PharmacyServices, Lotvin Alan, sold 2,781 shares at a price of $83.67 on Jun 28. Then, on Jun 15, EVP and Chief Medical Officer Brennan Troyen A sold 67,552 shares at a price of $86.00 per share. This transaction amounted to $5,809,472.
The company’s PE ratio for the last five years has touched a high of 27.07 and a low of 9.016. CVS stock has a beta of 0.79. Moving on to other valuation ratios, the trailing price-to-sales (P/S) ratio is 0.40 while the price-to-book (PB) in the most recent quarter is 1.51, with the price to cash flow ratio at 12.26.
CVS Health Corporation pays an annual dividend of $2.00 per share. Its dividend yield is 2.39% and the payout ratio is 36.50%. CVS paid $0.50 a share compared with prior rate of $0.50, down 0.0% from last year’s. The company latest dividend increase of $0.0750 reported on Thursday December 22 2016.
It is projected that CVS Health Corporation’s next ex-dividend date will be on 21-Oct-2021. CVS is expected to distribute $0.50 as its next dividend.
CVS Health Corporation’s quick ratio for the period ended June 29 was 0.70, with the current ratio over the same period at 1.00 meaning that CVS stock is not able to fulfill its debt obligations. As well, the company’s long term debt to equity for the quarter ending June 29 was 0.81, while the total debt to equity was 0.81. In terms of profitability, the gross margin trailing 12 months is 39.70%. The trailing 12-month EBITDA margin is 6.84% while for the period ending June 29; CVS Health Corporation’s operating margin was 4.40%. The firm’s gross profit as reported stood at $104.72 billion against revenue of $268.71 billion.
For the quarterly period ending June 29 this year, CVS Health Corporation’s cash and short-term investments amounted to $3.01 billion against total debt of $79.65 billion. Net income and sales went up compared to those figures reported in the previous quarter. Analysts expected CVS to announce $2.06 per share in earnings in its latest quarter, but it posted $2.42, representing a 17.50% surprise. EBITDA for the quarter stood at more than $5.46 billion. CVS stock balance sheet for the quarter ending June 29 shows that total liabilities totaled 157.6 billion, with total debt at $79.65 billion. Shareholders hold equity totaling $1.32 billion
Let’s look briefly at CVS Health Corporation (CVS) price momentum from a technical analysis perspective. The 9-day relative strength index as at close on 12 October was 43.34% to suggest the stock is trending Neutral, with historical volatility in this time period at 13.64%.
The stock’s 5-day moving average is $83.96, reflecting a +0.18% or $0.15 change from its current price. CVS is currently trading -0.12% above its 20-day SMA, -5.93% above its 100-day SMA. However, the stock’s current price level is away from the SMA50 and SMA200 by +1.67% and +23.27% respectively.
Stochastic %K and %D was 41.16% and 40.56% and the average true range (ATR) pointed at 1.57. The RSI (14) points at 45.77%, while the 14-day stochastic is at 34.96% with the period’s ATR at 1.59. The stock’s 9-day MACD Oscillator is pointing at 0.13 and -0.42 on the 14-day charts.
In the most recent analyst report for CVS Health Corporation (NYSE: CVS), Wells Fargo launched coverage with an Equal weight rating. Analysts offering their rating for CVS stock have a consensus rating for the stock as Overweight. Currently, 0 brokerage advisors rate CVS as a “sell,”, while 6 advise that investors “Hold.” 0 analysts have rated the stock as underweight. 4 rates the stock as overweight while 16 have offered a “buy” rating.
What is CVS’s price target for the next 12 months?
Analysts have a consensus price target ranging from a low of $80.00 and a high of $114.00, with their median price target at $97.15. Looking at these predictions, the average price target given by analysts is for CVS Health Corporation (CVS) stock is $96.15.